110 filings
Page 2 of 6
8-K
nnsb69wu
14 Nov 22
ReShape Lifesciences Announces $750,000 Registered Direct Offering
6:19am
8-K
9isxafv 2usy
15 Aug 22
ReShape Lifesciences™ Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:07pm
8-K
2eeb 0ok058z7ux
2 Aug 22
ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer
4:09pm
8-K
auac9j4y
25 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
9ch2q
21 Jul 22
Changes in Registrant's Certifying Accountant
4:05pm
8-K
jrknp
23 Jun 22
Entry into a Material Definitive Agreement
4:38pm
8-K
7qnup4b ohh1
23 May 22
ReShape Lifesciences™ Reports First Quarter 2022 Financial Results and Provides Corporate Update
10:33am
8-K
5a2p5p fs7fxus5
14 Apr 22
Changes in Registrant's Certifying Accountant
5:12pm
8-K
fdhzykhlkl
28 Mar 22
ReShape Lifesciences™ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update
5:30pm
8-K
fu24 oenn
17 Mar 22
Results of Operations and Financial Condition
8:35am
8-K
gmtofl 7rt78ewy
12 Nov 21
ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results
3:38pm
8-K
amuio33
16 Aug 21
ReShape Reports Second Quarter 2021 Financial Results and Provides Business Update
11:18am
8-K
qqt0ym7oq
19 Jul 21
Entry into a Material Definitive Agreement
8:01am
8-K
zs7rt3h k9n
2 Jul 21
Entry into a Material Definitive Agreement
4:05pm
8-K
safdz2
15 Jun 21
Completion of Acquisition or Disposition of Assets
5:11pm
8-K
hibguhzc
15 Jun 21
Announce Anticipated Closing of Merger
12:20pm
8-K
xalht1lr
26 May 21
Submission of Matters to a Vote of Security Holders
6:02am
8-K
umadcl9
21 May 21
Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
9:02am
8-K
n1qo8idm
18 May 21
Other Events
4:07pm
8-K
a13iv0h5q2khe9ocd7
13 May 21
Other Events
4:03pm